CNS pipeline · person
Jon S. Saxe, J.D., LL.M.
Independent director of Vistagen since 2000 and Chair of its Audit Committee; served as Board Chair until October 2023. Retired President of PDL BioPharma and former President and CEO of Synergen (acquired by Amgen); earlier VP, Licensing & Corporate Development and Head of Patent Law at Hoffmann-Roche.
- 1 company
Current roles
- Vistagen Therapeutics, Inc.Independent Director · Board2000–present
Appears with
People sharing a company with Jon.
- Ann M. Cunningham · Vistagen Therapeutics, Inc.
- Cynthia L. Anderson · Vistagen Therapeutics, Inc.
- Elissa Cote · Vistagen Therapeutics, Inc.
- Gerard Sanacora · Vistagen Therapeutics, Inc.
- Gordon Keller · Vistagen Therapeutics, Inc.
- Joanne Curley · Vistagen Therapeutics, Inc.
- Joshua S. Prince · Vistagen Therapeutics, Inc.
- Margaret M. FitzPatrick · Vistagen Therapeutics, Inc.
- Mark Wallace · Vistagen Therapeutics, Inc.
- Mary L. Rotunno · Vistagen Therapeutics, Inc.
- Maurizio Fava · Vistagen Therapeutics, Inc.
- Michael R. Liebowitz · Vistagen Therapeutics, Inc.
- Reid G. Adler · Vistagen Therapeutics, Inc.
- Sanjay Mathew · Vistagen Therapeutics, Inc.
- Shawn K. Singh · Vistagen Therapeutics, Inc.
- Thomas Laughren · Vistagen Therapeutics, Inc.
People and affiliation data assembled from public company disclosures, SEC filings, and conference materials — every record source-cited under psychiatrist-authored guardrails.